A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

California Clinical Trials Medical Group (CCTMG), Glendale, California, United States

Children's Hospital Los Angeles, Los Angeles, California, United States

Rush University Medical Center, Chicago, Illinois, United States

LA Center for Bleeding and Clotting Disorders - Metairie, Metairie, Louisiana, United States

University of Michigan Hospitals - Michigan Medicine, Ann Arbor, Michigan, United States

Washington University School of Medicine, St Louis, Missouri, United States

Brody School of Medicine at East Carolina University, Greenville, North Carolina, United States

Penn State Milton S Hershey Medical Center Pediatrics, Hershey, Pennsylvania, United States

Perelman Center for Advanced Medicine (PCAM)- Penn Blood Disorders Program, Philadelphia, Pennsylvania, United States

McMaster University Medical Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada